ArticleJournal of global health2025

Characteristics of indications, clinical trial evidence, clinical benefits and the costs of price-negotiated multi-indication drugs for solid tumours in China.

Pei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.